This page lists all pharmaceutical reports related to the field of Neurodegenerative & Neuroelectrophysiological Disorders. The reports include market research reports and pipeline analyses.
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Proteomics - Technologies, Markets and Companies
- Neuroprotection - Drugs, Markets and Companies
- Transdermal Drug Delivery - Technologies, Markets, and Companies
- Nitric Oxide - Therapeutics, Markets and Companies
- Alzheimer disease - new drugs, markets and companies
- Gene Therapy - technologies, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Biomarkers - technologies,markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Cannabinoid Market Forecasts & Analysis to 2012
- Early Toxicology: Markets and Approaches
- Multiple Sclerosis World Market Outlook to 2011
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007
- Cell-Based Assays for Drug Discovery
- Personalized Medicine
- MULTIPLE SCLEROSIS - Therapy Area Pipeline Report
- ISCHEMIA - Therapy Area Pipeline Report
- STROKE - Therapy Area Pipeline Report
- ALZHEIMER DISEASE - Therapy Area Pipeline Report
- EPILEPSY - Therapy Area Pipeline Report
- PARKINSON DISEASE - Therapy Area Pipeline Report
- SEIZURES - Therapy Area Pipeline Report
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Multiple Sclerosis Market Analysis and Forecasts Report 2007-2022
- Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
- Coxibs - Past Problems and Future Potential
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- How to Conduct Clinical Trials in China
- Alzheimers Disease Market analysis and forecasts, 2007-2022
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Parkinson's Disease Market analysis and forecasts
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Neuronal Nicotinic Receptors - April 2008
- Outsourcing in Drug Discovery
- Neuronal Nicotinic Receptors - June 2008
- Neuronal Nicotinic Receptors - July 2008
- The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
- Therapeutic Monoclonal Antibodies Report 2008-2023
- Neuronal Nicotinic Receptors - August 2008
- Neuronal Nicotinic Receptors - September 2008
- Ion Channel Trends 2008
- Kinase Screening & Profiling Trends 2008
- GPCR Screening & Profiling Trends 2008
- Neuronal Nicotinic Receptors - October 2008
- Neuronal Nicotinic Receptors - November 2008
- Two pharmaceutical reports for the price of one - End of year offer
- Medical Imaging Markets
- Protein Therapeutics Markets: Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines
- Alzheimers Disease Biomarkers, 2009
- UpdatesPlus Nicotinic Receptors - Current Research and Development - February 2009
- Point of Care Testing - Special Conference
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2009
- The Global Multiple Sclerosis Market 2009-2024
- Stem Cells - World Analysis 2009-2024
- Companion Biomarkers in Drug Development
- Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
- Therapeutic Monoclonal Antibodies Markets
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- UpdatesPlus Nicotinic Receptors - Current Research and Development - June 2009
- UpdatesPlus Nicotinic Receptors - Current Research and Development - July 2009
- UpdatesPlus Nicotinic Receptors - Current Research and Development - September 2009
- Stroke: Competitive Treatments and Market Entry Considerations, 2010
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- World Neurodegenerative Diseases Market 2009-2024
- Amyotrophic Lateral Sclerosis - Therapy Area Pipeline Report
- World Neurodegenerative Diseases Market 2009-2024
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Alzheimer's Disease: Current Treatment Practices and Opportunities, 2010
- Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
- The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis
- Biomarkers in Parkinson's Disease, 2010
- Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015
- Global Multiple Sclerosis Drug Market 2010-2025
- Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015
- Epilepsy - Drug Pipeline Analysis and Market Forecasts to 2015
- Multiple Sclerosis - Drug Pipeline Analysis and Market Forecasts to 2015
- Regenerative Medicine Markets
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Neurology Devices Market Outlook in United States to 2016 - Neurostimulation Devices, Interventional Neurology and Others
- Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Devices, Interventional Neurology and Others
- CNS Clinical Trials: World Market Prospects 2011-2026
- US Pharmaceutical Market Outlook 2011-2021
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Epidemiology: Parkinson's Disease
- Future Directions in Regenerative Medicine
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2011
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- R&D Trends: Multiple Sclerosis (MS) - Progressive subtypes remain underserved in expansive pipeline
- UpdatesPlus Nicotinic Receptors and Addiction - Current Research and Development - April/May 2011
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Anticonvulsants Market to 2016 - Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies
- Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Neupro (Parkinson's Disease) - Analysis and Forecasts to 2020
- Eldepryl (Parkinson's Disease) – Analysis and Forecasts to 2012
- Azilect (Parkinson's Disease) – Analysis and Forecasts to 2020
- Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain Growth
- Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
- Apokyn (Parkinson's Disease) – Analysis and Forecasts to 2020
- Tasmar (Parkinson's Disease) – Analysis and Forecasts to 2020
- Stalevo (Parkinson's Disease) – Analysis and Forecasts to 2020
- Comtan (Parkinson's Disease) - Analysis and Forecasts to 2020
- KW-6002 (Parkinson's Disease) – Analysis and Forecasts to 2020
- IPX066 (Parkinson's Disease) – Analysis and Forecasts to 2020
- Trerief (Parkinson's Disease) – Analysis and Forecasts to 2020
- Requip XL (Parkinson's Disease) – Analysis and Forecasts to 2020
- Mirapex (Parkinson's Disease) – Analysis and Forecasts to 2020
- Mirapex ER (Parkinson's Disease) – Analysis and Forecasts to 2020
- Pardoprunox (Parkinson's Disease) – Analysis and Forecasts to 2020
- Preladenant (Parkinson's Disease) – Analysis and Forecasts to 2020
- Safinamide (Parkinson's Disease) – Analysis and Forecasts to 2020
- Zelapar (Parkinson's Disease) – Analysis and Forecasts to 2020
- Requip (Parkinson's Disease) – Analysis and Forecasts to 2020
- Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
